207 related articles for article (PubMed ID: 322504)
1. Immunologic surface markers in non-Hodgkin's lymphomas.
Cossman J; Schnitzer B; Deegan MJ
Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
[TBL] [Abstract][Full Text] [Related]
2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
3. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
[TBL] [Abstract][Full Text] [Related]
6. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
[TBL] [Abstract][Full Text] [Related]
7. Immunological markers in non-Hodgkin's lymphomas.
Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
10. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
Byrne GE
Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
[TBL] [Abstract][Full Text] [Related]
11. Immunologic classification of non-Hodgkin's lymphomas: current status.
Seligmann M; Brouet JC; Preud'homme JL
Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
[No Abstract] [Full Text] [Related]
12. Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions.
Jaffe ES; Shevach EM; Sussman EH; Frank M; Green I; Berard CW
Br J Cancer Suppl; 1975 Mar; 2():107-20. PubMed ID: 1081000
[TBL] [Abstract][Full Text] [Related]
13. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
14. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
15. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
Cohnen G; Augener W; Douglas SD; König E; Brittinger G
Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
[No Abstract] [Full Text] [Related]
16. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
17. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
Weiss LM; Yousem SA; Warnke RA
Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
[TBL] [Abstract][Full Text] [Related]
19. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
Cartun RW; Coles FB; Pastuszak WT
Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
[TBL] [Abstract][Full Text] [Related]
20. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
